Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validationKatherine A. Hutcheson, Jan S. Lewin, Joanne Patterson et al.|Cancer|2016Cited by 254
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid CarcinomaJennifer Wang, Maria E. Cabanillas, Mark Zafereo et al.|Thyroid|2019Cited by 229
Sebaceous carcinoma: evidence-based clinical practice guidelinesJoshua L. Owen, Michael K. Wong, Nour Kibbi et al.|The Lancet Oncology|2019Cited by 204
Initial Management of <i>BRAF </i>V600E-Variant Anaplastic Thyroid CancerSarah Hamidi, Maria E. Cabanillas, Ramona Dadu et al.|JAMA Oncology|2024Cited by 35
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapyNaimah Turner, Roza Nurieva, Sarah Hamidi et al.|Frontiers in Immunology|2024Cited by 11